Cilostazol
Back to searchMolecule Structure
Scientific Name
Cilostazol
Description of the Drug
Cilostazol is an antiplatelet agent and vasodilator used for the symptomatic relief of intermittent claudication.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01166
http://www.drugbank.ca/drugs/DB01166
Brand Name(s)
Cilostazol, Pletal
Company Owner(s)
Nostrum Laboratories Inc, Epic Pharma Llc, Teva Pharmaceuticals Usa Inc, Apotex Inc Etobicoke Site, Otsuka Pharmaceutical Co Ltd, Chartwell Rx Sciences Llc, Pliva Hrvatska Doo, Actavis Elizabeth Llc, Slate Run Pharmaceuticals Llc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Phosphodiesterase 3A | SINGLE PROTEIN | INHIBITOR | CHEMBL241 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL16128 | |
PharmGKB | PA164746334 | |
Human Metabolome Database | HMDB0015297 | |
DrugBank | DB01166 | |
PubChem: Thomson Pharma | 14755273 | 14828756 |
PubChem | 2754 | |
Mcule | MCULE-8893820969 | |
LINCS | LSM-3491 | |
Nikkaji | J23.223H | |
BindingDB | 50225508 | |
EPA CompTox Dashboard | DTXSID9045132 | |
DrugCentral | 644 | |
Brenda | 4160 | |
ChemicalBook | CB2362876 | |
Guide to Pharmacology | 7148 | |
rxnorm | CILOSTAZOL | |
PubChem: Drugs of the Future | 12012700 | |
ChEBI | 31401 | |
ZINC | ZINC000001552174 |